Company Filing History:
Years Active: 2024-2025
Title: The Innovative Contributions of Evanthia Galanis
Introduction
Evanthia Galanis is a prominent inventor based in Rochester, MN (US). She has made significant strides in the field of cancer treatment through her innovative research and development. With a total of 2 patents, her work focuses on utilizing advanced materials and methods to combat cancer effectively.
Latest Patents
Evanthia Galanis holds two notable patents related to cancer treatment. The first patent discusses materials and methods for treating cancer, specifically involving the use of oncolytic viruses. This document outlines how these viruses can be employed to treat cancer in mammals, including humans, who are likely to respond positively to oncolytic virotherapy. The second patent also addresses cancer treatment, detailing methods and materials that utilize inhibitors of UFM1 and UFL1 activities. These inhibitors aim to enhance the sensitivity of cancer cells to DNA damaging therapies, such as radiation and chemotherapy.
Career Highlights
Evanthia Galanis is affiliated with the Mayo Foundation for Medical Education and Research, where she continues to contribute to groundbreaking research in oncology. Her work is characterized by a commitment to improving cancer treatment methodologies and patient outcomes.
Collaborations
Evanthia collaborates with esteemed colleagues, including S Keith Anderson and Cheyne B Kurokawa, to advance her research initiatives. These collaborations enhance the depth and breadth of her work, fostering innovation in cancer treatment.
Conclusion
Evanthia Galanis exemplifies the spirit of innovation in the medical field, particularly in cancer research. Her patents and ongoing work at the Mayo Foundation for Medical Education and Research highlight her dedication to improving treatment options for cancer patients.